Molecular Cell · 2023 · 67 citations · 60 references
MedicineCell BiologyOncologyCancer PharmacologyCell ProliferationMolecular OncologyCell Cycle ControlCell Cycle PharmacologyCell Cycle SignalingCell-cycle DysregulationOncogenic Signaling PathwaysSynthetic LethalityCancer Cell SenescenceCell Cycle Arrest MechanismsCell Cycle InhibitionCell Cycle InhibitorsDna Damage InductionG1 Cell-cycle ArrestG1 Phase ArrestOncogenic Transformation
CDK4/6 inhibitors are remarkable anti-cancer drugs that can arrest tumor cells in G1 and induce their senescence while causing only relatively mild toxicities in healthy tissues. How they achieve this mechanistically is unclear. We show here that tumor cells are specifically vulnerable to CDK4/6 inhibition because during the G1 arrest, oncogenic signals drive toxic cell overgrowth. This overgrowth causes permanent cell cycle withdrawal by either preventing progression from G1 or inducing genotoxic damage during the subsequent S-phase and mitosis. Inhibiting or reverting oncogenic signals that converge onto mTOR can rescue this excessive growth, DNA damage, and cell cycle exit in cancer cells. Conversely, inducing oncogenic signals in non-transformed cells can drive these toxic phenotypes and sensitize the cells to CDK4/6 inhibition. Together, this demonstrates that cell cycle arrest and oncogenic cell growth is a synthetic lethal combination that is exploited by CDK4/6 inhibitors to induce tumor-specific toxicity.
60
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin, Ignacio Arganda‐Carreras, Erwin Frise et al. · Nature Methods · 2012 · 70.9K citations
Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a
Manuel Serrano, Athena W. Lin, Mila E. McCurrach et al. · Cell · 1997 · 5.1K citations · Full text
Medicine, Cell Biology, Oncology +10
Visualizing Spatiotemporal Dynamics of Multicellular Cell-Cycle Progression
Asako Sakaue-Sawano, Hiroshi Kurokawa, Toshifumi Morimura et al. · Cell · 2008 · 2.3K citations · Full text
Life Sciences, Biology, Cell Biology +14
Hiroshi Hirai, Hiroshi Sootome, Yoko Nakatsuru et al. · Molecular Cancer Therapeutics · 2010 · 938 citations · Full text
Medicine, Oncology, Pharmacology +17